|
Weekly carfilzomib, lenalidomide, and dexamethasone (KRd) in relapsed or refractory multiple myeloma (RRMM): A phase 1b study. |
| |
|
Honoraria - Amgen; Celgene; Sanofi; Takeda |
Consulting or Advisory Role - Amgen; Celgene; Takeda |
Speakers' Bureau - Amgen; Celgene; Sanofi; Takeda |
Research Funding - Amgen; Celgene |
Travel, Accommodations, Expenses - Amgen; Celgene; Takeda |
| |
David Samuel DiCapua Siegel |
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen Oncology; Karyopharm Therapeutics; Merck; Takeda |
Speakers' Bureau - Amgen; Celgene; Janssen Oncology; Takeda |
Research Funding - Celgene (Inst) |
| |
|
Research Funding - Abbvie (Inst); Amgen (Inst); Bluebird Bio (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech/Roche (Inst); Glenmark (Inst); Janssen (Inst); Novartis (Inst); poseida therapeutics (Inst); Takeda (Inst); Teva (Inst) |
| |
|
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Merck; Novartis; Takeda |
Research Funding - AstraZeneca (Inst) |
| |
|
No Relationships to Disclose |
| |
|
Honoraria - Amgen; Celgene; Janssen |
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene |
Speakers' Bureau - Amgen; Janssen |
Research Funding - Bristol-Myers Squibb |
| |
|
Consulting or Advisory Role - Amgen; Celgene |
Research Funding - Abbvie; Amgen |
| |
|
|
| |
|
No Relationships to Disclose |
| |
|
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Medscape; Onyx |
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Onyx |
|
Travel, Accommodations, Expenses - Celgene; Millennium; Onyx |